United Therapeutics Corp UTHR

$591.17 -0.36% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 PRIMARY DOCUMENT 2026-11-13 View →
4 PRIMARY DOCUMENT 2026-11-12 View →
4 PRIMARY DOCUMENT 2026-11-12 View →
4 PRIMARY DOCUMENT 2026-11-10 View →
4 PRIMARY DOCUMENT 2026-11-10 View →
4 PRIMARY DOCUMENT 2026-11-10 View →
4 PRIMARY DOCUMENT 2026-11-09 View →
4 PRIMARY DOCUMENT 2026-11-06 View →
4 PRIMARY DOCUMENT 2026-11-06 View →
4 PRIMARY DOCUMENT 2026-11-05 View →
4 PRIMARY DOCUMENT 2026-11-05 View →
4 PRIMARY DOCUMENT 2026-11-05 View →
4 PRIMARY DOCUMENT 2026-11-04 View →
8-K 8-K 2026-11-04 View →
10-Q 10-Q 2026-11-04 View →
4 PRIMARY DOCUMENT 2026-11-03 View →
4 PRIMARY DOCUMENT 2026-11-02 View →
4 PRIMARY DOCUMENT 2026-10-30 View →
4 PRIMARY DOCUMENT 2026-10-29 View →
4 PRIMARY DOCUMENT 2026-10-28 View →
4 PRIMARY DOCUMENT 2026-10-27 View →
4 PRIMARY DOCUMENT 2026-10-26 View →
4 PRIMARY DOCUMENT 2026-10-23 View →
4 PRIMARY DOCUMENT 2026-10-22 View →
8-K FORM 8-K 2026-10-22 View →
4 PRIMARY DOCUMENT 2026-10-21 View →
4 PRIMARY DOCUMENT 2026-10-20 View →
4 PRIMARY DOCUMENT 2026-10-19 View →
4 PRIMARY DOCUMENT 2026-10-16 View →
4 PRIMARY DOCUMENT 2026-10-16 View →
4 PRIMARY DOCUMENT 2026-10-15 View →
4 PRIMARY DOCUMENT 2026-10-14 View →
8-K FORM 8-K 2026-10-14 View →
4 PRIMARY DOCUMENT 2026-10-13 View →
4 PRIMARY DOCUMENT 2026-10-13 View →
4 PRIMARY DOCUMENT 2026-10-09 View →
4 PRIMARY DOCUMENT 2026-10-08 View →
4 PRIMARY DOCUMENT 2026-10-07 View →
4 PRIMARY DOCUMENT 2026-10-06 View →
4 PRIMARY DOCUMENT 2026-10-05 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$591.17
Market Cap
$25.18 billion
52-Week Range
$409.07 – $614.23
Average Volume
636K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.